Unlock instant, AI-driven research and patent intelligence for your innovation.

Potassium ion binding polymers for pharmaceutical compositions

An acrylic polymer, application technology, applied in the direction of synthetic polymer material active ingredients, drug combination, drug delivery, etc., can solve the problem of diuretic efficacy limitation and the like

Active Publication Date: 2013-08-21
VIFOR PHARMA TECH LTD
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Diuretics allow the patient to eliminate sodium and potassium via the kidneys, but diuretic efficacy is often limited by pre-existing renal disease and associated diuretic resistance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Potassium ion binding polymers for pharmaceutical compositions
  • Potassium ion binding polymers for pharmaceutical compositions
  • Potassium ion binding polymers for pharmaceutical compositions

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0220] Example 1: Preparation of polymers with high binding energy

[0221] All chemicals were purchased from commercial sources and all chemical reactions were performed under nitrogen atmosphere. The chemical structural formulas and corresponding abbreviated symbols are listed in Tables 6 and 7.

[0222] Table 6. Abbreviated symbols and structural formulas of monomers

[0223]

[0224]

[0225] Table 7. Abbreviated symbols and structural formulas of crosslinking agents

[0226]

[0227]

[0228] Initiator: VA-044: 2,2'-Azobis[2-(2-imidazolin-2-yl)propane] dihydrochloride; K 2 S 2 o 8 , Potassium persulfate.

[0229] General method for preparing gels from FAA:

[0230] First, add FAA, X-V-1 and water into a 15mL test tube, then put a magnetic stir bar. The mixture was stirred at 45°C for 20 minutes. Then, VA-044 (100 mg / mL in water) was added to colloid the solution and kept at 45° C. for 4 hours, and then cooled to room temperature.

[0231] The gel wa...

Embodiment 2

[0254] Embodiment 2: binding energy screening method

[0255] All experiments were performed in duplicate. Two aliquots of approximately 30 mg each were placed in glass test tubes of 16 x 100 mm for each polymer. Dowex 50W and Amberlite CG-50 were included in each assay as internal controls. The relevant assay binding buffer (buffer 1, buffer 2 or buffer 3 see below) was added to a final resin concentration of 2.5 mg / mL. After the test tube was sealed with a Teflon membrane, it was incubated at room temperature while continuously rotating upside down for at least 1 hour, so that the combination of the cation and the polymer reached equilibrium. The tube was then centrifuged at 500 g for 30 minutes to separate the resin. Take the supernatant sample and use ion chromatography (IC) to determine potassium (K + eq ) and sodium (Na + eq ) at the equilibrium concentration. Will K + eq and Na + eq Concentration (K + 起始 and Na + 起始 ) for comparison, the binding energy...

Embodiment 3

[0276] Example 3: Method for predicting cation binding in the human gastrointestinal tract

[0277] This method is used to simulate the use conditions of potassium-binding drugs, and to determine the binding characteristics of polymers for potassium (target solute) in the presence of other competing cations. Mock food was prepared and simulated digestion was performed in the presence of pepsin and pancreatic juice. Both the order of enzyme addition and the pH profile were controlled to simulate digestion down to the jejunum. Lithium-preloaded polymers were added to the digested simulated food and left for a period of time to allow equilibrium to be achieved. Then the mixture was centrifuged, and the supernatant was taken. Determination of Na by ion chromatography + 、K + , NH 4 + , Ca 2+ and Mg 2+ . Lithium liberated was calculated as total cation exchange, while decreased concentrations of other cations were used to calculate their binding variables in Western foods...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The invention provides pharmaceutical compositions comprising potassium binding polymers. Methods of use of the polymeric and pharmaceutical compositions for therapeutic and / or prophylactic benefits are disclosed herein. Examples of these methods include the treatment of hyperkalemia, such as hyperkalemia caused by renal failure and / or the use of hyperkalemia causing drugs.

Description

[0001] This application is a divisional application of the invention patent application No. 200580010526.7 with the filing date of March 30, 2005 and the title of the invention being "ion-binding polymer and its application". [0002] cross reference [0003] This application is a continuation-in-part of US Application Serial No. 10 / 965,274, filed October 13,2004. The latter is a continuation in part of the following applications: US Application Serial No. 10 / 814,527, filed March 30, 2004, US Application Serial No. 10 / 814,749, filed March 30, 2004, and US Application Serial No. 10 / 813,872, filed March 30, 2004. These applications are incorporated by reference in their entirety into this application. Background technique [0004] Potassium (K + ) is the most abundant cation in the cell, and its content in the human body is about 35-40mEq / kg. See Agarwal, R, et al. (1994) Gastroenterology 107:548-571; Mandal, AK (1997) Med Clin North Am 81:611-639. Only 1.5-2.5% of this i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/50A61K31/78A61K47/32A61P3/12A61K9/14A61K9/16A61K9/32A61K31/74A61K45/06A61K47/30
CPCA61K45/06A61K9/5031A61K31/74A61K9/5026A61K47/32A61K9/1635A61K31/78A61K31/785A61K31/795A61K31/80A61P1/16A61P13/12A61P3/00A61P3/12A61P3/14A61P39/02A61P39/04A61P43/00A61P5/16A61P7/00A61P7/08A61P9/00A61P9/04A61P9/10A61P9/12A61K47/52A61K9/2027A61K9/2031A61K47/34A61K9/2846A61K9/14A61K47/50A61K9/28C08F120/06C08F128/02
Inventor 多米尼克·沙尔莫张汉廷格里特·克莱纳迈克尔·詹姆斯·科普刘明军刘福田托尼·K-K·孟
Owner VIFOR PHARMA TECH LTD